While the complex functions of each subset in various tumor types remain poorly described and require further investigation, it is generally accepted that Th1 cells promote effective anti-tumor immune responses via the production of large amounts of IFNγ, promoting not only CD8+ CTL function but also recruiting NK cells and classically activated M1 macrophages (73). The gene discussed is CD8A; the disease is neoplasm.